In colon cancer, phosphorylated TRM9L links oxidative stress and cell cycle control and proliferation by interacting with 14-3-3 proteins, revealing TRM9L is a crucial downstream effector of the ERK molecular axis117. Here, TRMT9B is linked to malignant colon neoplasm.